Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Ophthalmic Tacrolimus vs Cyclosporine for Ocular GVHD
NCT06348602Phase 2Recruiting
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Aug 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tacrolimus Ointment 0.1% Iwaki in ocular graft-versus-host disease (oGVHD), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Started Aug 2023; status: recruiting.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
ocular graft-versus-host disease (oGVHD)
Beyond the preview
Go deeper on NCT06348602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06348602.